Dr. Barry David Zevin, MD

Dr. Zevin practices at Zuckerberg San Francisco General Hospital and Trauma Center in San Francisco, California, part of City and County of San Francisco, CA.

Dr. Zevin's NPI, 1508938887, was assigned on November 14, 2006. Dr. Zevin graduated from Lewis Katz School of Medicine in 1988. Dr. Zevin holds California license G71721.

Dr. Zevin's primary practice is Zuckerberg San Francisco General Hospital and Trauma Center, at 1001 Potrero Avenue, San Francisco, CA 94110 in San Francisco County. The practice phone is (415) 206-8000.

Dr. Zevin's primary practice is Zuckerberg San Francisco General Hospital and Trauma Center in San Francisco, California, part of City and County of San Francisco, CA. The medical group on file is San Francisco Public Health Laboratory. Dmand AI also links Dr. Zevin to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zevin practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Zevin's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Zevin is board certified in addiction medicine by the American Board of Addiction Medicine. Dr. Zevin is licensed in California.

Dmand AI lists acid reflux, acute skin infection, anxiety, bipolar disorder, chronic anemia, chronic diabetes, chronic kidney disease and facial skin infection among the conditions Dr. Zevin treats.

CMS data shows 83 Medicare services from Dr. Zevin across 2 procedure codes in 2024, all of them office visits, for 72 Medicare patients. Medicare paid $10,827 for them. Every service was in an office.

CMS counts 72 Medicare patients who saw Dr. Zevin in 2024. The largest group is 65 to 74, with 34 patients. 60% of them have alcohol and drug use disorders, and 53% have anxiety. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zevin's median patient age at 51, with 10% women.

In 2024, Dr. Zevin wrote 272 Medicare Part D claims for 48 patients. 83% of them were for generic drugs. CMS names the drug for 84 of them, across 6 drugs with 11 or more claims each, at $11,127 in total drug cost. In 2023, CMS named 36 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Zevin for performance year 2024, reported as part of a group.

Dmand AI links 14 papers to Dr. Zevin, published from 2019 to 2025. 2021 was the busiest year, with 4. The most frequent topics are Ill-Housed Persons, San Francisco and Drug Overdose. Dr. Zevin has published most often in J Urban Health. Dr. Zevin's most frequent co-authors are Mandana Khalili, MD, Phillip Oliver Coffin, MD and Monica Gandhi, MD.

CMS Open Payments shows 1 general payment to Dr. Zevin from 1 drug or device company in 2017. Food and beverage make up the largest share, 100% of the total. Merck Sharp & Dohme Corporation paid the most, $17.

Dr. Zevin graduated from Lewis Katz School of Medicine in 1988.

Dr. Zevin is in network with 1 carrier, including CMS Medicare. Medicare plans come from the most carriers, 1. Check the plan with the practice before a visit.